Body
Shirley Ryan Â鶹APP recently signed on to take part in the (LLPR), a new project aimed at advancing treatments and outcomes for patients with congenital and acquired limb loss and limb difference.
Under the LLPR, Shirley Ryan Â鶹APP and other organizations will collect universal data elements that subsequently link hospital-, provider- and patient-reported outcomes over time.
¡°This quality improvement registry will collect national data on those with congenital and acquired limb loss,¡± said Levi Hargrove, PhD, scientific chair, Regenstein Center for Bionic Medicine, Shirley Ryan Â鶹APP, ¡°Â鶹APPers and clinicians will then be able to use that data to ensure that future amputation research and clinical and therapeutic treatments are based on reliable evidence to make informed analytical decisions.¡±
Mentioned Profile
Levi Hargrove, PhD
Vice President, Strategic Â鶹APP Infrastructure Scientific Chair, The Regenstein Center for Bionic MedicineBody
The LLPR represents key stakeholders including healthcare providers, researchers, regulators, manufacturers, payers, and industry and patient groups. It is currently being led by the Mayo Clinic and is under contract with the National Institutes of Health (NIH).
